These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 448944)

  • 21. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of gout.
    Cohen MG
    Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
    Wong ML
    N Z Med J; 2005 Jun; 118(1217):U1533. PubMed ID: 15980907
    [No Abstract]   [Full Text] [Related]  

  • 24. Febuxostat--treatment for hyperuricemia and gout?
    Moreland LW
    N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099
    [No Abstract]   [Full Text] [Related]  

  • 25. [Uricosuric agent].
    Ohno I
    Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approach to the treatment of hyperuricemia.
    Poon SH; Hall HA; Zimmermann B
    Med Health R I; 2009 Nov; 92(11):359-62. PubMed ID: 19999894
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of hyperuricemia and gout].
    Gröbner W; Walter-Sack I
    Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
    [No Abstract]   [Full Text] [Related]  

  • 30. The efficacy of treatment with allopurinol versus uricosuric drugs in gout.
    Weinberger A; Pinkhas J
    Panminerva Med; 1978; 20(3):155-6. PubMed ID: 757280
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of asymptomatic hyperuricemia].
    Floege J
    Internist (Berl); 1997 Dec; 38(12):1233. PubMed ID: 9465329
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of the gout and other forms of crystal-induced arthritis.
    Rodnan GP
    Bull Rheum Dis; 1982; 32(5):43-53. PubMed ID: 6762236
    [No Abstract]   [Full Text] [Related]  

  • 33. The treatment of hyperuricemia in gout.
    Rastegar A; Thier SO
    Ration Drug Ther; 1974 Mar; 8(3):1-4. PubMed ID: 4820829
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical inquiry. Are serum uric acid levels always elevated in acute gout?
    Leiszler M; Poddar S; Fletcher A
    J Fam Pract; 2011 Oct; 60(10):618-20. PubMed ID: 21977490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 36. An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
    Becker MA; Fitz-Patrick D; Choi HK; Dalbeth N; Storgard C; Cravets M; Baumgartner S
    Semin Arthritis Rheum; 2015 Oct; 45(2):174-83. PubMed ID: 26190562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Febuxostat versus allopurinol for gout.
    Lustberg ME
    N Engl J Med; 2006 Apr; 354(14):1532-3; author reply 1532-3. PubMed ID: 16598054
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of gout.
    Goldfinger SE
    N Engl J Med; 1971 Dec; 285(23):1303-6. PubMed ID: 4941493
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperuricemia and gout.
    Sloan RW
    J Fam Pract; 1982 May; 14(5):923-6, 930-1, 934. PubMed ID: 7042900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Uricoeliminating or urico-inhibiting agents? Reasons for a choice].
    Cottin S; Prost A
    Sem Hop; 1972 May; 48(24):1739-42. PubMed ID: 4340887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.